| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |